xylazine has been researched along with desoxycorticosterone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Citino, SB; Dawson, R; Schumacher, J | 1 |
Cabral, AM; da Silva, IF; Gardioli, CR; Menegaz, RG | 1 |
4 other study(ies) available for xylazine and desoxycorticosterone
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of a carfentanil-xylazine combination on cardiopulmonary function and plasma catecholamine concentrations in female bongo antelopes.
Topics: Analgesics, Opioid; Animals; Antelopes; Blood Pressure; Carbon Dioxide; Desoxycorticosterone; Drug Interactions; Female; Fentanyl; Hemodynamics; Hydrogen-Ion Concentration; Injections, Intramuscular; Norepinephrine; Oximetry; Oxygen; Partial Pressure; Respiration; Time Factors; Xylazine | 1997 |
Chronic activation of central alpha2-adrenoceptors prevents hypertension in DOCA-salt rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Desoxycorticosterone; Heart Rate; Hypertension, Renal; Injections, Intraventricular; Kidney; Male; Nephrectomy; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Sodium, Dietary; Sympathetic Nervous System; Xylazine; Yohimbine | 2000 |